Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Amyloidosis as a Cause of Cystic Pulmonary Fibrosis Associated With Pulmonary Nodules.

García-Sánchez A, Villasante C, Esteban-Rodriguez I, García-Río F F.

Arch Bronconeumol. 2018 Sep;54(9):481-482. doi: 10.1016/j.arbres.2018.01.018. Epub 2018 Apr 13. English, Spanish. No abstract available.

2.

Bronchiectasis in severe asthma: Clinical features and outcomes.

Coman I, Pola-Bibián B, Barranco P, Vila-Nadal G, Dominguez-Ortega J, Romero D, Villasante C, Quirce S.

Ann Allergy Asthma Immunol. 2018 Apr;120(4):409-413. doi: 10.1016/j.anai.2018.02.016. Epub 2018 Feb 27.

PMID:
29496464
3.

A 60-Year-Old Male Smoker With Chronic Obstructive Pulmonary Disease and Hypereosinophilia.

Sánchez-Jareño M, Yuste Jiménez V, Villasante C, Canales MÁ, Álvarez-Sala R.

Arch Bronconeumol. 2018 Jan 17. pii: S0300-2896(17)30440-4. doi: 10.1016/j.arbres.2017.11.016. [Epub ahead of print] English, Spanish. No abstract available.

4.

Dynamic hyperinflation in patients with asthma and exercise-induced bronchoconstriction.

Mediano O, Casitas R, Villasante C, Martínez-Cerón E, Galera R, Zamarrón E, García-Río F.

Ann Allergy Asthma Immunol. 2017 Apr;118(4):427-432. doi: 10.1016/j.anai.2017.01.005. Epub 2017 Feb 14.

PMID:
28214133
5.

Forward genetic screen of human transposase genomic rearrangements.

Henssen AG, Jiang E, Zhuang J, Pinello L, Socci ND, Koche R, Gonen M, Villasante CM, Armstrong SA, Bauer DE, Weng Z, Kentsis A.

BMC Genomics. 2016 Aug 4;17:548. doi: 10.1186/s12864-016-2877-x.

6.

Systemic inflammation and higher perception of dyspnea mimicking asthma in obese subjects.

Carpio C, Villasante C, Galera R, Romero D, de Cos A, Hernanz A, García-Río F.

J Allergy Clin Immunol. 2016 Mar;137(3):718-26.e4. doi: 10.1016/j.jaci.2015.11.010. Epub 2016 Jan 5.

PMID:
26768410
7.

Genomic DNA transposition induced by human PGBD5.

Henssen AG, Henaff E, Jiang E, Eisenberg AR, Carson JR, Villasante CM, Ray M, Still E, Burns M, Gandara J, Feschotte C, Mason CE, Kentsis A.

Elife. 2015 Sep 25;4. pii: e10565. doi: 10.7554/eLife.10565.

8.

The diagnostic challenges of separating chronic ulcerative stomatitis from oral lichen planus.

Qari H, Villasante C, Richert J, Rees T, Kessler H.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Nov;120(5):622-7. doi: 10.1016/j.oooo.2015.07.018. Epub 2015 Jul 22.

PMID:
26337216
9.

Sputum periostin in patients with different severe asthma phenotypes.

Kimura H, Suzuki M, Konno S, Nishimura M, Bobolea I, Barranco P, Del Pozo V, Romero D, Sanz V, López-Carrasco V, Canabal J, Villasante C, Quirce S.

Allergy. 2015 Jul;70(7):884-5. doi: 10.1111/all.12639. No abstract available.

PMID:
26081263
10.

Sputum periostin in patients with different severe asthma phenotypes.

Bobolea I, Barranco P, Del Pozo V, Romero D, Sanz V, López-Carrasco V, Canabal J, Villasante C, Quirce S.

Allergy. 2015 May;70(5):540-6. doi: 10.1111/all.12580. Epub 2015 Feb 18. Erratum in: Allergy. 2015 Jul;70(7):886.

PMID:
25631525
11.

Oxygenation With a Single Portable Pulse-Dose Oxygen-Conserving Device and Combined Stationary and Portable Oxygen Delivery Devices in Subjects With COPD.

Yáñez AM, Prat JP, Álvarez-Sala JL, Calle M, Díaz Lobato S, García Gonzalez JL, Rodríguez Gonzalez-Moro JM, Galera-Martínez R, Villasante C, Ramos I, Franco-Gay M, de Lucas P.

Respir Care. 2015 Mar;60(3):382-7. doi: 10.4187/respcare.03470. Epub 2014 Nov 25.

12.

Prognostic value of the objective measurement of daily physical activity in patients with COPD.

Garcia-Rio F, Rojo B, Casitas R, Lores V, Madero R, Romero D, Galera R, Villasante C.

Chest. 2012 Aug;142(2):338-346. doi: 10.1378/chest.11-2014.

PMID:
22281798
13.

Involvement of Spanish pulmonology centers in patient care, postgraduate education and research in asthma: the results of the ATENEA survey.

Plaza V, Bellido-Casado J, Díaz C, Pérez de Llano L, Sanchis J, Villasante C, López Viña A.

Arch Bronconeumol. 2012 Apr;48(4):114-9. doi: 10.1016/j.arbres.2011.11.001. Epub 2012 Jan 2. English, Spanish.

14.

Bronchial reactivity indices are determinants of health-related quality of life in patients with stable asthma.

Cisneros C, García-Río F, Romera D, Villasante C, Girón R, Ancochea J.

Thorax. 2010 Sep;65(9):795-800. doi: 10.1136/thx.2010.137844.

PMID:
20805173
15.

Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007.

Soriano JB, Ancochea J, Miravitlles M, García-Río F, Duran-Tauleria E, Muñoz L, Jiménez-Ruiz CA, Masa JF, Viejo JL, Villasante C, Fernández-Fau L, Sánchez G, Sobradillo-Peña V.

Eur Respir J. 2010 Oct;36(4):758-65. doi: 10.1183/09031936.00138409. Epub 2009 Dec 8.

16.

Lung volume reference values for women and men 65 to 85 years of age.

Garcia-Rio F, Dorgham A, Pino JM, Villasante C, Garcia-Quero C, Alvarez-Sala R.

Am J Respir Crit Care Med. 2009 Dec 1;180(11):1083-91. doi: 10.1164/rccm.200901-0127OC. Epub 2009 Sep 10.

PMID:
19745204
17.

Exhaled nitric oxide and airway caliber during exercise-induced bronchoconstriction.

García-Río F, Ramírez M, Mediano O, Lores V, Rojo B, Villasante C, Villamor J.

Int J Sports Med. 2006 Nov;27(11):905-10.

PMID:
17120347
18.

[Comparison of carbon dioxide rebreathing during application of continuous positive airway pressure with 3 types of nasal mask].

Mediano O, García-Río F, Villasante C.

Arch Bronconeumol. 2006 Apr;42(4):189-93. Spanish.

19.

Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers.

Miravitlles M, Ferrer M, Pont A, Luis Viejo J, Fernando Masa J, Gabriel R, Jiménez-Ruiz CA, Villasante C, Fernández-Fau L, Sobradillo V.

Respir Med. 2005 Aug;99(8):985-95. Epub 2005 Mar 4.

20.

Cost-effectiveness of formoterol and salbutamol as asthma reliever medication in Sweden and in Spain.

Lindgren B, Sears MR, Campbell M, Villasante C, Huang S, Lindh A, Petermann W, Svensson K, Berggren F, Pauwels RA; RELIEF study investigators.

Int J Clin Pract. 2005 Jan;59(1):62-8.

PMID:
15707467
21.

Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease?

Jiménez-Ruiz C, Miravitlles M, Sobradillo V, Gabriel R, Viejo JL, Masa JF, Fernández-Fau L, Villasante C.

Nicotine Tob Res. 2004 Aug;6(4):649-53.

PMID:
15370161
22.

[Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population-based study].

Masa JF, Sobradillo V, Villasante C, Jiménez-Ruiz CA, Fernández-Fau L, Viejo JL, Miravitlles M.

Arch Bronconeumol. 2004 Feb;40(2):72-9. Spanish.

23.

Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial.

Pauwels RA, Sears MR, Campbell M, Villasante C, Huang S, Lindh A, Petermann W, Aubier M, Schwabe G, Bengtsson T; RELIEF Study investigators.

Eur Respir J. 2003 Nov;22(5):787-94.

24.

Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.

Vaquerizo MJ, Casan P, Castillo J, Perpiña M, Sanchis J, Sobradillo V, Valencia A, Verea H, Viejo JL, Villasante C, Gonzalez-Esteban J, Picado C; CASIOPEA (Capacidad de Singulair Oral en la Prevencion de Exacerbaciones Asmaticas) Study Group.

Thorax. 2003 Mar;58(3):204-10. Erratum in: Thorax. 2003 Apr;58(4):370.

25.

[Respiratory symptoms and diagnosis of COPD in smokers of various types to tobacco. Results from the IBERPOC study].

Jiménez-Ruiz CA, Sobradillo V, Gabriel R, Viejo JL, Masa JF, Miravitlles M, Villasante C, Fernández-Fau L.

Arch Bronconeumol. 2002 Nov;38(11):530-5. Spanish.

26.

Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma.

Ind PW, Villasante C, Shiner RJ, Pietinalho A, Böszörményi NG, Soliman S, Selroos O.

Eur Respir J. 2002 Oct;20(4):859-66.

27.

Inspiratory neural drive response to hypoxia adequately estimates peripheral chemosensitivity in OSAHS patients.

García-Río F, Pino JM, Ramirez T, Alvaro D, Alonso A, Villasante C, Villamor J.

Eur Respir J. 2002 Sep;20(3):724-32.

28.

Interpretation of quality of life scores from the St George's Respiratory Questionnaire.

Ferrer M, Villasante C, Alonso J, Sobradillo V, Gabriel R, Vilagut G, Masa JF, Viejo JL, Jiménez-Ruiz CA, Miravitlles M.

Eur Respir J. 2002 Mar;19(3):405-13.

29.

Reduction of lung distensibility in acromegaly after suppression of growth hormone hypersecretion.

García-Río F, Pino JM, Díez JJ, Ruíz A, Villasante C, Villamor J.

Am J Respir Crit Care Med. 2001 Sep 1;164(5):852-7.

PMID:
11549545
30.

Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD.

Jiménez-Ruiz CA, Masa F, Miravitlles M, Gabriel R, Viejo JL, Villasante C, Sobradillo V.

Chest. 2001 May;119(5):1365-70.

PMID:
11348940
31.

Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study.

Peña VS, Miravitlles M, Gabriel R, Jiménez-Ruiz CA, Villasante C, Masa JF, Viejo JL, Fernández-Fau L.

Chest. 2000 Oct;118(4):981-9.

PMID:
11035667
32.

[Prevalence of and attitudes towards smoking in a population over 40 years of age].

Jiménez Ruiz CA, Fernando Masa J, Sobradillo V, Gabriel R, Miravitlles M, Fernández-Fau L, Villasante C, Viejo JL.

Arch Bronconeumol. 2000 May;36(5):241-4. Spanish.

33.

Sleep apnea and hypertension.

García-Río F, Racionero MA, Pino JM, Martínez I, Ortuño F, Villasante C, Villamor J.

Chest. 2000 May;117(5):1417-25.

PMID:
10807831
34.

[The internal consistency and content validity of the Spanish version of the Asthma Autonomy Questionnaire].

Perpiñá M, Sobradillo V, Castillo J, Duce F, Manresa F, Martínez J, Valencia A, Viejo JL, Villasante C.

Arch Bronconeumol. 2000 Feb;36(2):90-4. Spanish.

35.

[Information seeking and decision making in asthmatic patients].

Perpiñá M, Sobradillo V, Castillo J, Duce F, Manresa F, Martínez J, Valencia A, Viejo JL, Villasante C.

Arch Bronconeumol. 1999 Oct;35(9):435-9. Spanish.

PMID:
10596340
36.

[Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation].

Sobradillo V, Miravitlles M, Jiménez CA, Gabriel R, Viejo JL, Masa JF, Fernández-Fau L, Villasante C.

Arch Bronconeumol. 1999 Apr;35(4):159-66. Spanish.

PMID:
10330536
37.

[Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): recruitment and field work].

Miravitlles M, Sobradillo V, Villasante C, Gabriel R, Masa JF, Jiménez CA, Fernández-Fau L, Viejo JL.

Arch Bronconeumol. 1999 Apr;35(4):152-8. Spanish.

PMID:
10330535
38.

Changing ventilator: An option to take into account in the treatment of persistent vomiting during nasal ventilation.

Díaz Lobato S, Garcia Tejero MT, Ruiz Cobos A, Villasante C.

Respiration. 1998;65(6):481-2.

PMID:
9817964
39.

Long-term within-subject variability of inspiratory neural drive response to hypoxia.

García-Río F, Pino-García JM, Racionero MA, Terreros-Caro JG, Gómez-Mendieta MA, Prados C, Villasante C.

Chest. 1998 Aug;114(2):521-5.

PMID:
9726740
40.

[Cytohistologic consistency of transthoracic puncture-aspiration with fine needle in malignant lesions].

García Río F, Díaz Lobato S, Villasante C.

Arch Bronconeumol. 1998 Mar;34(3):166. Spanish. No abstract available.

PMID:
9611643
41.

[Factors influencing economic cost of home oxygen therapy].

Díaz Lobato S, Pino García JM, Villasante C.

Med Clin (Barc). 1998 Mar 7;110(8):303-6. Spanish. No abstract available.

PMID:
9567259
42.

Comparison of helium dilution and plethysmographic lung volumes in pregnant women.

García-Río F, Pino-García JM, Serrano S, Racionero MA, Terreros-Caro JG, Alvarez-Sala R, Villasante C, Villamor J.

Eur Respir J. 1997 Oct;10(10):2371-5.

43.

[Ambulatory oxygen therapy via transtracheal catheter].

Díaz Lobato S, García Tejero MT, Villasante C.

Arch Bronconeumol. 1997 Apr;33(4):205-6. Spanish. No abstract available.

PMID:
9280567
44.

[Nocturnal pneumology hospitals].

Díaz Lobato S, García Tejero MT, Ruiz Cobos A, Villasante C.

Arch Bronconeumol. 1997 Feb;33(2):89-91. Spanish. No abstract available.

PMID:
9091120
45.

[Home oxygen therapy with transtracheal catheter].

Díaz Lobato S, Pino JM, Ruiz Cobos MA, Villasante C.

Rev Clin Esp. 1996 Dec;196(12):846-50. Review. Spanish. No abstract available.

PMID:
9132862
46.

Thoracic pain and abnormal chest radiograph.

Alba D, Díaz Lobato S, Ruíz Cobos M, Villasante C.

Postgrad Med J. 1996 Oct;72(852):625-6. No abstract available.

47.

Regulation of breathing and perception of dyspnea in healthy pregnant women.

García-Rio F, Pino JM, Gómez L, Alvarez-Sala R, Villasante C, Villamor J.

Chest. 1996 Aug;110(2):446-53.

PMID:
8697850
48.

[An early detection program for respiratory insufficiency in Duchenne's disease: the preliminary results].

Díaz Lobato S, Gómez de Terreros FJ, García Tejero MT, Corral J, Vázquez C, Redondo MA, Echavarri C, Martínez J, Villasante C.

Arch Bronconeumol. 1996 Jun-Jul;32(6):267-70. Spanish.

PMID:
8814819
49.

[Ambulatory oxygen therapy via a transtracheal catheter].

Díaz Lobato S, García Tejero M, Racionero MA, García Río F, Villasante C, Villamor J.

Arch Bronconeumol. 1996 May;32(5):225-9. Spanish.

PMID:
8696646
50.

[Patient compliance to the prescription of domiciliary oxygen therapy by transtracheal catheter].

Díaz Lobato S, García Tejero MT, Villasante C.

Arch Bronconeumol. 1996 Apr;32(4):210-1. Spanish. No abstract available.

PMID:
8689023

Supplemental Content

Loading ...
Support Center